| Net Cash Provided by (Used in) Operating Activities |
-1,840,000 |
USD |
+80.7% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
10,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
450,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
16,100,692 |
shares |
+0.92% |
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
8,160,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
57,021,000 |
USD |
-39.1% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Valuation Allowance |
282,882,000 |
USD |
+2.4% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
282,882,000 |
USD |
+2.4% |
Q4 2024 |
FY 2024 |
| Depreciation |
7,400,000 |
USD |
|
Q1 2023 |
Q1 2024 |
| Payments to Acquire Property, Plant, and Equipment |
7,948,000 |
USD |
-63.7% |
Q1 2023 |
Q1 2024 |
| Property, Plant and Equipment, Gross |
229,100,000 |
USD |
+4.1% |
Q3 2023 |
Q3 2023 |
| Deferred Tax Assets, Operating Loss Carryforwards |
268,405,000 |
USD |
+15% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
300,000 |
shares |
|
Q1 2024 |
Q1 2024 |
| Additional Paid in Capital |
1,182,658,000 |
USD |
-0.21% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
300,000 |
shares |
|
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |